BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20708043)

  • 1. Protein quality control mechanisms and neurodegenerative disorders: Checks, balances and deadlocks.
    Mittal S; Ganesh S
    Neurosci Res; 2010 Nov; 68(3):159-66. PubMed ID: 20708043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction.
    Tai HC; Schuman EM
    Nat Rev Neurosci; 2008 Nov; 9(11):826-38. PubMed ID: 18931696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aggravating role of the ubiquitin-proteasome system in neurodegeneration.
    Ardley HC; Hung CC; Robinson PA
    FEBS Lett; 2005 Jan; 579(3):571-6. PubMed ID: 15670810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair.
    Bergink S; Severijnen LA; Wijgers N; Sugasawa K; Yousaf H; Kros JM; van Swieten J; Oostra BA; Hoeijmakers JH; Vermeulen W; Willemsen R
    Neurobiol Dis; 2006 Sep; 23(3):708-16. PubMed ID: 16860562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal inclusions in degenerative disorders Do they represent static features or a key to understand the dynamics of the disease?
    Fornai F; Soldani P; Lazzeri G; di Poggio AB; Biagioni F; Fulceri F; Batini S; Ruggieri S; Paparelli A
    Brain Res Bull; 2005 Apr; 65(4):275-90. PubMed ID: 15811592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative disorders.
    Iacovelli L; Fulceri F; De Blasi A; Nicoletti F; Ruggieri S; Fornai F
    Exp Neurol; 2006 Sep; 201(1):24-31. PubMed ID: 16678160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging roles for ubiquitin and protein degradation in neuronal function.
    Yi JJ; Ehlers MD
    Pharmacol Rev; 2007 Mar; 59(1):14-39. PubMed ID: 17329546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-related proteins in neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.
    Mori F; Tanji K; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Kamitani T; Yoshida M; Wakabayashi K
    Pathol Int; 2012 Jun; 62(6):407-11. PubMed ID: 22612509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein degradation, aggregation, and misfolding.
    Cuervo AM; Wong ES; Martinez-Vicente M
    Mov Disord; 2010; 25 Suppl 1():S49-54. PubMed ID: 20187257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.
    van Tijn P; Hol EM; van Leeuwen FW; Fischer DF
    Prog Neurobiol; 2008 Jun; 85(2):176-93. PubMed ID: 18448229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders.
    Mori F; Nishie M; Piao YS; Kito K; Kamitani T; Takahashi H; Wakabayashi K
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):53-61. PubMed ID: 15634231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms.
    Pizzi M; Spano P
    Eur J Pharmacol; 2006 Sep; 545(1):22-8. PubMed ID: 16854410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of protein conformational disturbances in the pathomechanism of the extrapyramidal system diseases].
    Dziewulska D; Rafałowska J
    Neurol Neurochir Pol; 2005; 39(5):397-404. PubMed ID: 16273464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells.
    Li Z; Arnaud L; Rockwell P; Figueiredo-Pereira ME
    J Neurochem; 2004 Jul; 90(1):19-28. PubMed ID: 15198663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.
    Zheng C; Geetha T; Babu JR
    Neurodegener Dis; 2014; 14(4):161-75. PubMed ID: 25413678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein ubiquitination, degradation and the proteasome in neuro-degenerative disorders: no clear evidence for a significant pathogenetic role of proteasome failure in Alzheimer disease and related disorders.
    Schmitt HP
    Med Hypotheses; 2006; 67(2):311-7. PubMed ID: 16580788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal intranuclear inclusion disease in a horse.
    Pumarola M; Vidal E; Trens JM; Serafín A; Marquez M; Ferrer I
    Acta Neuropathol; 2005 Aug; 110(2):191-5. PubMed ID: 15971054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.